Double-Donor transplant offers new hope for rare blood disease
NCT ID NCT07499284
Summary
This study is testing a two-part stem cell transplant for people with aplastic anemia, a serious blood disorder. It combines cells from a partially matched family donor with cells from donated umbilical cord blood. Researchers hope this combination helps the transplant succeed more reliably and reduces serious side effects. The study will measure how well patients survive, how quickly their blood counts recover, and their quality of life after the procedure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for APLASTIC ANAEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hematology Department, The First Affiliated Hospital of Soochow University
RECRUITINGSuzhou, Jiangsu, China 215006, China
-
Suzhou Hongci Hematology Hospital
RECRUITINGSuzhou, Jiangsu, China 215006, China
-
The Affiliated Hospital of Xuzhou Medical University
RECRUITINGXuzhou, Jiangsu, China 221006, China
-
The First Affiliated Hospital of Zhejiang Chinese Medical University
RECRUITINGHangzhou, Zhejiang, China 310006, China
Conditions
Explore the condition pages connected to this study.